Chemotherapy for Advanced Non–Small-Cell Lung Cancer in Elderly Patients

oncol edit

Autores: Fábio Nasser Santos, MD; Marcelo Rocha Souza Cruz, MD; Rachel Riera, MD, MSC, PhD


JAMA Oncology Clinical Evidence Synopsis • Doi: 10.1001/jamaoncol.2016.2050 • December 2016

 

Clinical Question  Do patients above 70 years of age with newly diagnosed advanced non–small-cell lung cancer benefit from platinum-based combination or should they receive non-platinum agents either as single-agent or in combination?

Bottom Line  For fit elderly patients platinum-based combination is associated with better overall survival, progression-free survival, and objective response rate, however this improvement should be counter balanced against the higher risk of major adverse events (AE).

Artigos Relacionados - Artigos Científicos

20 Jun 2017 17:05

Autores: Fábio Nasser Santos, MD; Marcelo Rocha Souza Cruz, MD; Rachel Riera, MD, [ ... ]

Artigos Cientificos
20 Jun 2017 17:05


Autores: Vladimir Vasconcelos, Nicolle Cassola, Edina MK da Silva, Jose CC Baptista-Silva

Cochrane [ ... ]

Artigos Cientificos
20 Jun 2017 14:22

Autor: Iared, Walter; Koga da Silva, edina Mariko; IAred, Wagner; Rufino Macedo, Cristiane

Artigos Cientificos

© 2013 - 2017 Universidade Federal de São Paulo - Unifesp

Rua Napoleão de Barros, 865 - Vila Clementino  •  CEP 04024-002 - São Paulo - SP
+55 11 5576 4848 VoIp 2184   •   pgsbeunifesp@gmail.com